8.Rossing P, Agarwal R, Bakris GL, et al. The rationale, design and baseline data of FLOW, a kidney outcomes trial in patients with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023;38(8):1626-1635 9.Perkovic V, Tut...
近日,全球糖尿病治疗领域迎来里程碑进展——诺和诺德宣布美国FDA正式批准其GLP-1受体激动剂Ozempic(司美格鲁肽)扩展适应症,用于降低合并慢性肾病(CKD)的2型糖尿病患者肾脏功能恶化、终末期肾病及心血管死亡风险。此次获批标志着GLP-1类药物首次突破糖尿病...
8.Rossing P, Agarwal R, Bakris GL, et al. The rationale, design and baseline data of FLOW, a kidney outcomes trial in patients with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023;38(8):1626-1635 9.Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, ...
大量流行病学研究结果证实,超重和肥胖是诱发血脂异常、非酒精性脂肪肝 (Nonalcoholic fatty liver disease, NAFLD)、代谢综合征 (Metabolic syndrome ,MetS )、心血管疾病 (Cardiovascular disease,CVD)、2型糖尿病 (type 2 diabetes mellitus,T2DM)、慢性肾病、多囊卵巢综合征(Polycystic ovary syndrome,PCOS)、睡眠...
大量流行病学研究结果证实，超重和肥胖是诱发血脂异常、非酒精性脂肪肝 (Nonalcoholic fatty liver disease, NAFLD)、代谢综合征 (Metabolic syndrome ，MetS )、心血管疾病 (Cardiovascular disease，CVD)、2型糖尿病 (type 2 diabetes mellitus，T2DM)、慢性肾病、多囊卵巢综合征(Polycystic ovary syndrome，PCOS)、...
Here we show that GLP-1 RAs are associated with lower risks of mortality, major cardiovascular events (MACEs), and major adverse kidney events (MAKEs) in type 2 diabetes patients with acute kidney disease (AKD). Utilizing global data from the TriNetX database (2002/09/01-2022/12/01) and...
大量流行病学研究结果证实,超重和肥胖是诱发血脂异常、非酒精性脂肪肝 (Nonalcoholic fatty liver disease, NAFLD)、代谢综合征 (Metabolic syndrome ,MetS )、心血管疾病 (Cardiovascular disease,CVD)、2型糖尿病 (type 2 diabetes mellitus,T2DM)、慢性肾病、多囊卵巢综合征(Polycystic ovary syndrome,PCOS)、睡眠...
[6]. Rossing P, Baeres FMM, Bakris G, et al. The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transp...
Rossing P, Agarwal R, Bakris GL, et al. The rationale, design and baseline data of FLOW, a kidney outcomes trial in patients with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023;38(8):1626-1635 Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris...
近日,德克萨斯大学西南医学中心的研究人员在 Nature 子刊 Nature Communications 上发表了题为:Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease 的研究论文。 该研究发现,与另一类常用的降糖药 DPP-4i 相比,胰高血糖素样肽-1 受体激动剂(GLP1-...